| Literature DB >> 34174863 |
Shuai Zhang1, Jin Yang1, Song Wang2, Qing Wang1, Shuang Xu1.
Abstract
BACKGROUND: Infection after vertebral augmentation (VA) often limits the daily activities of patients and even threatens their life. The operation may be one of the effective treatments if the patient suffers from intolerable severe pain, neurological deficits, and damage to spinal stability. This study aimed to investigate the clinical efficacy of the treatment of pyogenic spondylitis after vertebral augmentation (PSVA) with Single posterior debridement, vertebral body resection, and intervertebral bone graft fusion and internal fixation (sPVRIF).Entities:
Keywords: Clinical efficacy; Debridement; Pyogenic spondylitis; Single posterior approach; Vertebral augmentation
Mesh:
Year: 2021 PMID: 34174863 PMCID: PMC8236162 DOI: 10.1186/s12891-021-04478-0
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Demographics and comorbidities of patients and information on primary intervention
| Cases | Level(s) of fracture | Comorbidities | Type of intervention | CRP (mg/L) | ESR (mm/h) | WBC (10^9/L) | VAS | Neu (%) | Biopsy | Level of infection/type of fracture |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | T9,L2 | COPD,DM | KP | 7.2 | 28 | 7.6 | 6 | 49 | Negative | L2/OVCF |
| 2 | L3 | HTN,IHD | VP | NA | NA | NA | NA | NA | NA | L3/OVCF |
| 3 | T10,T11,T12 | HTN,CIS | KP | 10.7 | 46 | 6.4 | 7 | 62 | NA | T10/OVBF |
| 4 | L4 | HF,Af | VP | 8.3 | 19 | 6.7 | 5 | 63 | Negative | L4/Kummell |
| 5 | L2 | HTN,DM,UTI | KP | 21.3 | 44 | 7.8 | 6 | 74 | Chronic inflammation | L2/OVBF |
| 6 | L1,L2 | DM,CIS | KP | 17.6 | 36 | 8.2 | 6 | 68 | NA | L2/Kummell |
| 7 | T11 | Malnutrition,RI | KP | 11.4 | 29 | 5.4 | 5 | 59 | NA | T11/OVBF |
| 8 | T10,T11 | Obesity,HTN | KP | 13.6 | 33 | 5.9 | 4 | 62 | NA | T10/OVCF |
| 9 | L3,L4 | COPD,CIS | VP | NA | NA | NA | NA | NA | NA | L4/kummell |
| 10 | T8,T12 | DM,Malnutrition | KP | 8.3 | 16 | 6.2 | 6 | 63 | Negative | T12/OVBF |
| 11 | L1 | None | KP | 27.9 | 67 | 4.6 | 5 | 41 | Negative | L1/kummell |
| 12 | T12 | SLE | KP | 24.4 | 58 | 5.0 | 6 | 43 | NA | T12/OVCF |
| 13 | L1,L2 | PCa(chemotherapy) | VP | 19.6 | 41 | 3.9 | 5 | 39 | NA | L2/Kummell |
| 14 | T11 | Obesity,CIS | VP | 10.0 | 21 | 6.5 | 5 | 60 | Negative | T11/OVCF |
| 15 | T10,L1 | HTN | KP | 8.1 | 18 | 7.1 | 6 | 67 | Negative | L1/OVCF |
| 16 | T11,T12 | UTI,DM | VP | 20.4 | 39 | 8.5 | 6 | 79 | NA | T12/kummell |
| 17 | L1 | DM,HTN | VP | 11.3 | 20 | 8.2 | 6 | 69 | NA | L1/OVBF |
| 18 | L3,L4 | COPD,RI | KP | 8.3 | 17 | 7.1 | 4 | 63 | NA | L4/OVCF |
| 19 | T12,L1,L2 | Malnutrition, Decubitus | KP | 7.0 | 42 | 8.0 | 6 | 70 | NA | L2/OVBF |
CRP,C-reactive protein, ESR erythrocyte sedimentation rate, WBC white blood count, VAS visual analog scale, Neu neutrophil ratio, COPD chronic obstructive pulmonary disease. DM diabetes mellitus, KP Kyphoplasty, VP vertebroplasty, HTN hypertension, IHD ischemic heart disease, NA not available, CIS cerebral ischemic stroke, HF heart failure, Af artrial fibrillation, UTI urinary tract infection, RI renal insufficiency, SLE systemic lupus erythematosus, PCa prostatic cancer, OVCF Osteoporosis vertebral body compression fracture, OVBF Osteoporosis vertebral body burst fracture
Fig. 1A patient in this study suffered an OVF of the L1 vertebra due to a lumbar sprain. A–E Imaging data before PKP surgery did not indicate vertebral infection. F–G Re-examination after PKP showed that the height of the vertebral body was partially restored, and the location of bone cement in the vertebral body was satisfactory
Fig. 2After 3 months of PKP surgery, the patient was hospitalized again with severe lower-back pain and paraplegia of both lower limbs. A–D Imaging examination revealed that the bone cement in the L1 vertebral body was displaced, the bone of the T12/L1 vertebral body was destroyed, the thoracolumbar segment formed a kyphotic deformity centered on T12/L1, the corresponding level of spinal canal stenosis, and the dural sac compression. E–F Single posterior decompression of lesions and bone cement removal, spinal canal decompression, intervertebral bone graft fusion, pedicle screw internal fixation surgery, and postoperative spinal sequence complete recovery
Clinical, Laboratory, preoperative data of reoperation
| Cases | Reoperation after infection(d) | Fever/Chill | Neurologic deficites | CRP (mg/L) | ESR (mm/h) | WBC (10^9/L) | VAS | Neu (%) |
|---|---|---|---|---|---|---|---|---|
| 1 | 67 | + | None | 45.7 | 62 | 11.4 | 7 | 77 |
| 2 | 103 | + | None | 81.3 | 59 | 9.8 | 7 | 81 |
| 3 | 14 | - | None | 109.7 | 48 | 13.5 | 8 | 89 |
| 4 | 88 | - | Paraparesis | 35.6 | 109 | 10.9 | 9 | 82 |
| 5 | 97a | - | Radiculopathy | 40.2 | 77 | 9.6 | 9 | 79 |
| 6 | 135 | + | Paraparesis | 18.9 | 68 | 11.1 | 7 | 80 |
| 7 | 373 | + | None | 22.7 | 60 | 9.0 | 6 | 69 |
| 8 | 26b | - | Paraparesis | 173.7 | 114 | 15.2 | 7 | 91 |
| 9 | 54 | - | None | 40.9 | 95 | 8.3 | 9 | 83 |
| 10 | 61 | + | None | 73.8 | 87 | 10.5 | 8 | 74 |
| 11 | 108 | - | None | 36.9 | 124 | 11.7 | 7 | 79 |
| 12 | 157 | + | Radiculopathy | 18.7 | 108 | 9.5 | 6 | 71 |
| 13 | 19 | - | None | 142.3 | 77 | 14.6 | 7 | 88 |
| 14 | 182a | - | Paraparesis | 40.6 | 84 | 10.8 | 9 | 82 |
| 15 | 71 | + | None | 87.7 | 79 | 12.3 | 8 | 87 |
| 16 | 114 | - | None | 39.0 | 56 | 10.4 | 7 | 70 |
| 17 | 93 | + | Paraparesis | 45.5 | 38 | 7.9 | 6 | 69 |
| 18 | 21 | + | None | 109.0 | 103 | 10.8 | 10 | 78 |
| 19 | 49 | + | None | 92.5 | 81 | 14.1 | 8 | 89 |
CRP C-reactive protein, ESR erythrocyte sedimentation rate, WBC white blood count, VAS visual analog scale, Neu neutrophil ratio
aConservative treatment
bAbandoning therapy
Operative and postoperative data
| Cases | Treatment method | Operative time(min) | Blood loss(ml) | Causative | Follow-up(month) | Outcome | VAS follow-up | Bony fusion |
|---|---|---|---|---|---|---|---|---|
| 1 | Operation | 165 | 500 | No organism | 9.2 | Normal | 2 | Fusion |
| 2 | Operation | 190 | 400 | Enterococcus faecalis | 5.3 | Normal | 1 | Partial fusion |
| 3 | Operation | 185 | 350 | Non-tuberculous mycobacterium | Died | NA | NA | NA |
| 4 | Operation | 210 | 450 | Micromonomonas | 17.5 | Wheelchair | 2 | Fusion |
| 5 | Conservative treatment | NA | NA | NA | Died | NA | NA | NA |
| 6 | Operation | 180 | 400 | No organism | 23.5 | Use a walker | 3 | Fusion |
| 7 | Operation | 170 | 300 | MRSE | 8.5 | Normal | 2 | Fusion |
| 8 | None | NA | NA | NA | Died | NA | NA | NA |
| 9 | Operation | 160 | 350 | Tread fungus | 33.5 | Use a walker | 1 | Fusion |
| 10 | Operation | 160 | 300 | S.albus | 23.0 | Normal | 1 | Fusion |
| 11 | Operation | 210 | 650 | Streptococcus | 12.0 | Normal | 2 | Fusion |
| 12 | Operation | 155 | 300 | No organism | 7.5 | Wheelchair | 2 | Partial fusion |
| 13 | Operation | 165 | 400 | S.aureus | 15.5 | Died(cancer) | NA | Fusion |
| 14 | Conservative treatment | NA | NA | NA | 24.0 | Use a walker | 3 | Spontaneous fusion |
| 15 | Operation | 180 | 900 | Enterococcus faecalis | 3.0 | Normal | 1 | Partial fusion |
| 16 | Operation | 160 | 700 | S.aureus | NA | NA | NA | NA |
| 17 | Operation | 165 | 400 | No organism | 8.0 | Normal | 2 | Fusion |
| 18 | Operation | 170 | 500 | Streptococcus | NA | NA | NA | NA |
| 19 | Operation | 175 | 550 | Escherichia coli | 10.0 | Normal | 1 | Fusion |
VAS visual analog scale, NA not available, MRSE methicillin resistant Staphylococcus epidermidis, S.albus Staphylococcus albus, S.aureus Staphylococcus aureus